Fresenius
€43.67Change from previous close: −0.29%Absolute change: −€0.13
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €24.6B
- Enterprise value
- €35.51B
- P/E (trailing 12 months)
- 15.8
- Forward P/E
- 11.0
- PEG
- 0.79
- Price/book
- 1.25
- Price/sales
- 1.06
- EV/EBITDA
- 11.7
- EV/revenue
- 1.53
Profitability and growth
- Gross margin
- 25.4%
- Operating margin
- 10.6%
- Net margin
- 6.5%
- ROE
- 8.3%
- ROA
- 3.4%
- Revenue growth (year over year)
- 5.2%
- Earnings growth (year over year)
- 17.2%
Financial health
- Total cash
- €1.28B
- Total debt
- €11.42B
- Debt/equity
- 0.56
- Current ratio
- 1.28
- Quick ratio
- 0.65
Dividends
- Annual dividend per share
- €1.05
- Dividend yield
- 2.4%
- Payout ratio
- 37.9%
- Ex-dividend date
- May 25, 2026
Analysts and estimates
- Average price target
- €55.59
- Median price target
- €55.60
- High price target
- €63.50
- Low price target
- €50.00
- Analysts with a price target
- 14
- Consensus
- Strong buy
- Forward EPS
- €3.95
- EPS estimate, current year
- €3.71
Shares and trading
- Beta
- 0.84
- Average volume
- 1.01M
- Shares outstanding
- 563.24M
- Float
- 410.56M
- Institutional ownership
- 43.8%
- Insider ownership
- 27.0%